Ultivue Announces Co-Marketing Agreement with Sirona DX for Multiplexed Tissue Biomarker Solutions for Precision Medicine
15.3.2022 16:00:00 CET | Business Wire | Press Release
Ultivue, Inc. an industry leader in multiplexing tools and novel image analysis solutions for tissue biomarker studies, and Sirona Dx, a technical contract research organization (CRO), providing advanced, single cell proteomics and genomics services to accelerate the pace of immunotherapy and targeted therapy development, announced a co-marketing agreement to deliver tissue-based spatial multiplexed immunophenotyping solutions for translational research groups and Biopharma.
Ultivue, a leader in advancing precision medicine solutions by accelerating tissue biomarker discovery and validation, develops unique solutions for use in both multiplex immunofluorescence (mIF) imaging and spatial phenomics. Its proprietary InSituPlex® technology, designed for fast and comprehensive exploration of biologically relevant targets, up to 12-plex, with same slide-H&E analysis in precious tissue samples combines the power of computational pathology & spatial biology to guide translational science in immuno-oncology. “Our InSituPlex technology offers valuable profiling of the tissue and expands the depth of information possible from a single section that is complementary to the high-parameter capabilities offered by Sirona Dx. We believe this joint offering will now provide researchers a seamless workflow enabling a far more efficient biomarker discovery and drug development process.” said Mark Rees, Ph.D. Vice President Corporate Development at Ultivue.
Sirona Dx are original pioneers of spatial biology, having launched ultra-high parameter, multiplexed imaging services to Biopharma in 2018. Their technology agnostic, full service, spatial biology suite, contributed to their selection as a Top 10 CRO of 2021 by Medhealth Outlook.
“We are delighted to announce this partnership with Ultivue” said Andrew Brown, Ph.D. Chief Commercial Officer at Sirona Dx. “Since 2018, clients have relied on our leading expertise to develop and implement customized, high performance multiplexed imaging panels of up to 40 markers. Having cast a wide net to identify the most informative tissue biomarker signatures, we can now harness Ultivue’s powerful InSituPlex® technology to rapidly develop, robustly validated mid-plex panels of up to 12 markers enabling our clients to accelerate their drug development programs with transformative biomarker capabilities.
About Sirona Dx
Sirona Dx is a technical CRO, founded to accelerate the pace of immunotherapy and targeted therapy development. Bridging silos between diagnostics manufacturers and translational clinical research our laboratory offers specialized high complexity, single cell proteomics and genomics services supporting pharmaceutical companies with their drug discovery and development programs. Learn more at Sironadx.com.
About Ultivue
Ultivue provides researchers and scientists in translational medicine with multiplex biomarker assays for tissue phenotyping and digital pathology. Its proprietary InSituPlex® technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions coupled with our scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs. Learn more at Ultivue.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220315005096/en/
Contact information
Ultivue
Mark Rees, Ph.D.
Vice President Corporate Development
Mobile : (+1) 516-512-4977
ULTIVUE
USA: 763D Concord Ave. Cambridge, MA 02138-1044
Europe: Via Calabria, 15. 20090 Segrate. Milan. Italy
Website: www.ultivue.com
E. mail: mark.rees@ultivue.com
Sirona Dx
Andrew Brown, Ph.D.
Chief Commercial Officer
Mobile : (+1) 503-816-9692
SIRONA DX
USA: 4640 SW Macadam Ave, Suite 200 D, Portland, OR 97239
Website: www.sironadx.com
E. mail abrown@sironadx.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Flick Raises $6M Seed Round to Redefine How AI Films Are Created14.5.2026 15:19:00 CEST | Press Release
Flick (flick.art), an AI-native filmmaking platform founded by award-winning filmmaker Zoey Zhang and founding Instagram engineer Ray Wang, today announced it has raised $6 million in a seed round from True Ventures, GV (Google Ventures), Y Combinator, Lightspeed, Formosa Capital, Pioneer Fund, Olive Tree Capital, and N1 in addition to angel investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514408256/en/ Flick was built around a simple belief: AI should enhance filmmaking, not replace it. Instead of another one-click video generator, Flick gives filmmakers cinematic control through an AI-native creative workflow designed for storytelling, iteration, and artistic direction. Flick will use the seed funding to accelerate product development, expand its core creative tooling for cinematic control, and grow the company’s community of filmmakers. The team is also launching Flick Filmmaker Residency,debuting with 10+ sho
PIF Named as Official Tournament Supporter of FIFA World Cup 2026™14.5.2026 15:08:00 CEST | Press Release
PIF and FIFA has announced PIF as an Official Tournament Supporter in North America and Asia of the FIFA World Cup 2026™. The partnership reflects a shared commitment to expanding the growth of football at every level, from the grassroots to elite competition, as well as enabling greater participation in sport by unlocking new opportunities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514974404/en/ 14 May, 2026: Front row (L-R), Romy Gai, Chief Business Officer, FIFA and Kevin Foster, Managing Director and Head of Corporate Affairs, PIF, back row (L-R), H.R.H Prince Faisal Bin Bandar Bin Sultan Al Saud, Vice Chairman, Savvy Games Group, Gianni Infantino, President, FIFA, H.E. Yasir Othman Al-Rumayyan, Governor, PIF and Muhannad AlDawood, Chief Strategy Officer, Qiddiya Investment Company witnessed the signing of the partnership of PIF as Official Tournament Supporter of FIFA World Cup 2026™, incorporating PIF companies
Viz.ai Launches Viz Pulmonary Suite, the First Comprehensive AI-Powered Solution Dedicated to Pulmonary Care Delivery14.5.2026 15:00:00 CEST | Press Release
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of the Viz Pulmonary™ Suite, an integrated AI-powered solution in the Viz.ai enterprise platform, designed to help health systems streamline care delivery for pulmonary conditions. The suite brings acute and chronic pulmonary workflows together in a single solution, giving clinicians a more streamlined way to manage patients to help get them on guideline-directed care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514994555/en/ With 55%-65% of potential in-network referrals lost due to health system leakage,1 improving continuity across the patient journey becomes a critical challenge. The Viz Pulmonary Suite, which integrates seamlessly with EHR systems, is designed to help pulmonary teams improve retention and outcomes by combining context-aware patient summaries and guideline surfacing with specialized tool
Xsolla Showcases Industry Insights and Regional Commitment at Digital Dragons 202614.5.2026 15:00:00 CEST | Press Release
Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announced its participation in Digital Dragons 2026, one of Europe’s premier game industry conferences. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514302984/en/ Graphic: Xsolla As the video game industry continues to evolve, early indicators from Q1 2026 point to sustained momentum across key segments. Xsolla’s presence at Digital Dragons will reflect on several emerging themes shaping the market, including: The ongoing strength of live-service and hybrid monetization models Increased adoption of direct-to-consumer (D2C) strategies by developers and publishers Growing demand for localized payment solutions to support global player bases A heightened focus on player engagement, retention, and community-building tools These insights underscore the industry’s shift toward long-term player relationships and div
AS Graanul Invest Appoints Energy Industry Veteran Lars Christian Bacher as Chief Executive Officer14.5.2026 14:45:00 CEST | Press Release
ASGraanul Invest (“Graanul” or the “Company”), Europe’s largest producer of sustainable wood pellets used for electricity and heat production, today announces energy industry veteran Lars Christian Bacher will be joining the business as Chief Executive Officer, effective 18 May. Bacher will drive the Company’s growth across Europe as Graanul doubles down on its strategy to provide its customers with sustainable fuel to enable the production of renewable, dispatchable power and heat. Outgoing Chief Executive Nicholas Dottino will support Bacher with his transition to his new role as an advisor to Apollo on infrastructure and energy investments. Bacher joins Graanul having previously worked at Norwegian multinational energy company Equinor as a member of the Executive Committee for over eight years, including two years as Chief Financial Officer, where he had responsibility for managing financial operations and strategic planning. Prior to this, he was executive Vice President, Developme
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom